Patent details

Basic Information

Publication number:

EP3463298

PCT Application Number:

CN2017086942

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP178058855

PCT Publication Number:

WO2017206940

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METRONOMIC ORAL GEMCITABINE FOR CANCER THERAPY

French Title of Invention:

GEMCITABINE MÉTRONOMIQUE ADMINISTRÉE PAR VOIE ORALE POUR LE TRAITEMENT DU CANCER

German Title of Invention:

METRONOMISCHES ORALES GEMCITABIN ZUR KREBSTHERAPIE

SPC Number:

Dates

Filing date:

02/06/2017

Grant date:

01/09/2021

EP Publication Date:

10/04/2019

PCT Publication Date:

07/12/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

01/09/2021

EP B1 Publication Date:

01/09/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

02/06/2022

Expiration date:

02/06/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

25/08/2021

 

 

Name:

Innopharmax, Inc.

Address:

9F., No.22, Lane 478 Rueiguang Rd. Neihu District, Taipei City 11492, Taiwan (TW)

Inventor

1

Name:

HSUEH, Shu-Piing

Address:

Taiwan (TW)

2

Name:

HAO, Wei-Hua

Address:

Taiwan (TW)

3

Name:

HSU, Chang-Shan

Address:

Taiwan (TW)

Priority

Priority Number:

201662344660 P

Priority Date:

02/06/2016

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/107; A61K 9/48; A61K 31/7068; A61P 35/00; A61K 47/14; A61K 9/00; A61K 47/10; A61K 47/26;

Publication

European Patent Bulletin

Issue number:

202135

Publication date:

01/09/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages